about
How can mathematical models advance tuberculosis control in high HIV prevalence settings?Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination.Bridging implementation, knowledge, and ambition gaps to eliminate tuberculosis in the United States and globallyBioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysisSurveying the Knowledge and Practices of Health Professionals in China, India, Iran, and Mexico on Treating TuberculosisTesting and treating the missing millions with tuberculosis.
P2860
Q26824057-F2B730F1-5B33-4AFD-A96D-577F4B2C4A5CQ34226104-B00F390D-E57B-4F22-A33A-598E30ED1110Q34382344-55024C70-1DDF-4FB1-BC42-ACEB3101869DQ35193579-2BD85C7A-27DA-43B6-8FB1-49EDB8C55423Q36111327-3F4C9BD3-2789-4C55-8517-E8E7BECF2E4AQ36869629-CF1DADCF-BE5F-4ED1-AFE7-6843EB7F3BB6Q43201202-AF6E30EA-9073-4778-99D1-0D177C4C12D4
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Global investments in TB control: economic benefits.
@en
Global investments in TB control: economic benefits.
@nl
type
label
Global investments in TB control: economic benefits.
@en
Global investments in TB control: economic benefits.
@nl
prefLabel
Global investments in TB control: economic benefits.
@en
Global investments in TB control: economic benefits.
@nl
P2093
P1433
P1476
Global investments in TB control: economic benefits.
@en
P2093
Olusoji Adeyi
Ramanan Laxminarayan
Sarah Darley
P304
P356
10.1377/HLTHAFF.28.4.W730
P407
P577
2009-06-30T00:00:00Z